Participants’ views on the benefits and challenges of having two therapists in psychedelic therapy

Cotherapy is commonly used in psychedelic-assisted therapy, particularly during sessions involving psilocybin for Generalised Anxiety Disorder (GAD).

• Participants' experiences with cotherapy in psychedelic-assisted therapy may provide insights into the therapeutic process.
• Cotherapy involves two therapists supporting participants during dosing and psychotherapy, which is a frequent model in clinical trials.
• The study focuses on understanding the dynamics and effectiveness of cotherapy in the context of psilocybin treatment for GAD.
• Insights from the experiences of participants could highlight the importance of therapist support during psychedelic sessions.

Simplified